These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 15581898)
1. APOBEC3G ubiquitination by Nedd4-1 favors its packaging into HIV-1 particles. Dussart S; Douaisi M; Courcoul M; Bessou G; Vigne R; Decroly E J Mol Biol; 2005 Jan; 345(3):547-58. PubMed ID: 15581898 [TBL] [Abstract][Full Text] [Related]
2. HIV-1 and MLV Gag proteins are sufficient to recruit APOBEC3G into virus-like particles. Douaisi M; Dussart S; Courcoul M; Bessou G; Vigne R; Decroly E Biochem Biophys Res Commun; 2004 Aug; 321(3):566-73. PubMed ID: 15358144 [TBL] [Abstract][Full Text] [Related]
3. Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging. Luo K; Liu B; Xiao Z; Yu Y; Yu X; Gorelick R; Yu XF J Virol; 2004 Nov; 78(21):11841-52. PubMed ID: 15479826 [TBL] [Abstract][Full Text] [Related]
4. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor. Schäfer A; Bogerd HP; Cullen BR Virology; 2004 Oct; 328(2):163-8. PubMed ID: 15464836 [TBL] [Abstract][Full Text] [Related]
5. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Yu X; Yu Y; Liu B; Luo K; Kong W; Mao P; Yu XF Science; 2003 Nov; 302(5647):1056-60. PubMed ID: 14564014 [TBL] [Abstract][Full Text] [Related]
6. Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G. Liu B; Yu X; Luo K; Yu Y; Yu XF J Virol; 2004 Feb; 78(4):2072-81. PubMed ID: 14747572 [TBL] [Abstract][Full Text] [Related]
7. APOBEC3G incorporation into human immunodeficiency virus type 1 particles. Zennou V; Perez-Caballero D; Göttlinger H; Bieniasz PD J Virol; 2004 Nov; 78(21):12058-61. PubMed ID: 15479846 [TBL] [Abstract][Full Text] [Related]
8. Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function. Kobayashi M; Takaori-Kondo A; Miyauchi Y; Iwai K; Uchiyama T J Biol Chem; 2005 May; 280(19):18573-8. PubMed ID: 15781449 [TBL] [Abstract][Full Text] [Related]
9. APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC basic linker. Burnett A; Spearman P J Virol; 2007 May; 81(10):5000-13. PubMed ID: 17344295 [TBL] [Abstract][Full Text] [Related]
10. The human immunodeficiency virus type 1 Vif protein reduces intracellular expression and inhibits packaging of APOBEC3G (CEM15), a cellular inhibitor of virus infectivity. Kao S; Khan MA; Miyagi E; Plishka R; Buckler-White A; Strebel K J Virol; 2003 Nov; 77(21):11398-407. PubMed ID: 14557625 [TBL] [Abstract][Full Text] [Related]
11. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion. Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139 [TBL] [Abstract][Full Text] [Related]
12. Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway. Mehle A; Strack B; Ancuta P; Zhang C; McPike M; Gabuzda D J Biol Chem; 2004 Feb; 279(9):7792-8. PubMed ID: 14672928 [TBL] [Abstract][Full Text] [Related]
13. Human apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like 3G (APOBEC3G) is incorporated into HIV-1 virions through interactions with viral and nonviral RNAs. Svarovskaia ES; Xu H; Mbisa JL; Barr R; Gorelick RJ; Ono A; Freed EO; Hu WS; Pathak VK J Biol Chem; 2004 Aug; 279(34):35822-8. PubMed ID: 15210704 [TBL] [Abstract][Full Text] [Related]
14. The interaction between HIV-1 Gag and APOBEC3G. Cen S; Guo F; Niu M; Saadatmand J; Deflassieux J; Kleiman L J Biol Chem; 2004 Aug; 279(32):33177-84. PubMed ID: 15159405 [TBL] [Abstract][Full Text] [Related]
15. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Sheehy AM; Gaddis NC; Malim MH Nat Med; 2003 Nov; 9(11):1404-7. PubMed ID: 14528300 [TBL] [Abstract][Full Text] [Related]
16. Functional domains of APOBEC3G required for antiviral activity. Li J; Potash MJ; Volsky DJ J Cell Biochem; 2004 Jun; 92(3):560-72. PubMed ID: 15156567 [TBL] [Abstract][Full Text] [Related]
17. The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles. Douaisi M; Dussart S; Courcoul M; Bessou G; Lerner EC; Decroly E; Vigne R Biochem Biophys Res Commun; 2005 Apr; 329(3):917-24. PubMed ID: 15752743 [TBL] [Abstract][Full Text] [Related]
18. New insights into the role of Vif in HIV-1 replication. Schröfelbauer B; Yu Q; Landau NR AIDS Rev; 2004; 6(1):34-9. PubMed ID: 15168739 [TBL] [Abstract][Full Text] [Related]
19. Human APOBEC3G incorporation into murine leukemia virus particles. Kremer M; Bittner A; Schnierle BS Virology; 2005 Jun; 337(1):175-82. PubMed ID: 15914230 [TBL] [Abstract][Full Text] [Related]
20. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Marin M; Rose KM; Kozak SL; Kabat D Nat Med; 2003 Nov; 9(11):1398-403. PubMed ID: 14528301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]